St. Jude and WHO to expand access globally to lifesaving cancer treatments
St. Jude announced Monday, Dec. 13, that it would invest $200 million over six years to launch the Global Platform for Access to Childhood Cancer Medicines. (Patrick Lantrip/Daily Memphian)
The WHO and St. Jude first collaborated in 2018 when St. Jude committed $15 million for the creation of the Global Initiative for Childhood Cancer.
Topics
St. Jude Children’s Research Hospital World Health Organization Global Platform for Access to Childhood Cancer MedicinesRob Moore
Rob Moore is an Arkansas native who moved to Memphis to attend the University of Memphis. He holds a B.A. and an M.A. in English. He covers Public Companies, Transportation and Logistics, and Banking and Finance.
Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here.
Our commenting policy can be viewed here.